attentiondeficitdisorder Newsletter

Attention Deficit Disorder

June 23 2017 Attention Deficit Disorder Newsletter

Here's the latest article from the Attention Deficit Disorder site at

Greetings from the Land of OZ!

After reading about these new meds, I had a tiny pity party. You see, I have glaucoma, so many, if not all, ADD meds are closed off for me. When I took meds, my focus was so laser-like! I've had glaucoma for more than 20 years, yet it hasn't progressed, and I am truly blessed to have vision. I'm concerned about upsetting the delicate glaucoma balance that keeps my optic nerves healthy, so I use non-medical interventions for my ADD. Sometimes the magic works, but often it doesn't. Wouldn't life be easier if the old brain had chemicals that were in balance? Would I still be me without my ADD? Hmmm!

Long-Acting Stimulant Meds for ADD
This week the news brought word of two new long-acting, stimulant medications approved by The US Food and Drug Administration (FDA) for Attention Deficit Disorder. One, Contempla, is aimed at children aged 6-17 years old. The other, Mydayis, was approved for ages 13-years old to adults.

Please visit for even more great content about Attention Deficit Disorder.

To participate in free, fun online discussions, this site has a community forum all about Attention Deficit Disorder located here -

I hope to hear from you sometime soon, either in the forum or in response to this email message. I thrive on your feedback!

Have fun passing this message along to family and friends, because we all love free knowledge!

Have a blessed week!

Connie Mistler Davidson, Attention Deficit Disorder Editor

One of hundreds of sites at

Unsubscribe from the Attention Deficit Disorder Newsletter

Online Newsletter Archive for Attention Deficit Disorder Site

Master List of BellaOnline Newsletters

Editor's Picks Articles
Top Ten Articles
Previous Features
Site Map